Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LATTICE SEMICONDUCTOR CORPLSCC · Entity 3335 | Director | May 04, 2026 | May 06, 2026 |
| MiniMed Group, Inc.MMED · Entity 3758 | Director · Chief Executive Officer | July 31, 2026 | August 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LATTICE SEMICONDUCTOR CORP
Report date May 04, 2026 · Filed May 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,237 |
Reported balance
After 2026-05-04 transaction · row 1
1 source rowRow 1 · 2026-05-04 · Grant · Acquired 1,752 · Balance 10,237 F1: Represents a grant of Restricted Stock Units (RSUs) which vest 100% on the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of Restricted Stock Units (RSUs) which vest 100% on the first anniversary of the date of grant.
MiniMed Group, Inc.
Report date July 31, 2026 · Filed August 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 884,749 |
Reported balance
After 2026-07-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-31 · Tax withholding · Disposed 31,350 · Balance 884,749 F1: Represents shares of Common Stock that have been withheld by MiniMed Group, Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs"). F2: Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Common Stock that have been withheld by MiniMed Group, Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs").
F2: Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HONEYWELL INTERNATIONAL INC
Report date May 01, 2022 · Filed May 03, 2022
Section 16 reporting ended · disclosed 2022-05-03. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2026 Filed Aug 4, 2026 21:38 UTC | MiniMed Group, Inc. MMED · Entity 3758 | Tax withholdingCommon Stock | 31,350 | $18.15 | $569,002.50 |
DisclosureSEC source: 0001756652-26-000004 · wk-form4_1785879529.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 884,749 F1 · shares: Represents shares of Common Stock that have been withheld by MiniMed Group, Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 21:37 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantCommon Stock | 297,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001756652-26-000002 · wk-form4_1783373854.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 916,099 F1 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. F3 · balance_after: Includes 1,727 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026. Read SEC document |
| May 04, 2026 Filed May 6, 2026 16:12 UTC | LATTICE SEMICONDUCTOR CORP LSCC · Entity 3335 | GrantCommon Stock | 1,752 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-015103 · rdgdoc.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,237 F1 · shares: Represents a grant of Restricted Stock Units (RSUs) which vest 100% on the first anniversary of the date of grant. Read SEC document |
| March 25, 2026 Filed Mar 27, 2026 20:31 UTC | MiniMed Group, Inc. MMED · Entity 3758 | Tax withholdingCommon Stock | 4,809 | $16.31 | $78,434.79 |
DisclosureSEC source: 0001628280-26-021752 · wk-form4_1774643481.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 616,754 F1 · shares: Represents shares of Common Stock that have been withheld by MiniMed Group, Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:23 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantCommon Stock | 22,892 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017827 · wk-form4_1773444228.xml · nonDerivative · entry 6 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,892 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F9 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in two equal installments on March 10, 2026 and March 10, 2027. F9 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in two equal installments on March 10, 2026 and March 10, 2027. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:23 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantCommon Stock | 51,044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017827 · wk-form4_1773444228.xml · nonDerivative · entry 5 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,044 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F8 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028. F8 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:23 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantCommon Stock | 80,842 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017827 · wk-form4_1773444228.xml · nonDerivative · entry 4 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,842 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F7 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 29, 2027. F7 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 29, 2027. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:23 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantCommon Stock | 57,239 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017827 · wk-form4_1773444228.xml · nonDerivative · entry 3 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,239 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F6 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 31, 2026. F6 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 31, 2026. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:23 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantCommon Stock | 127,609 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017827 · wk-form4_1773444228.xml · nonDerivative · entry 2 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,609 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F5 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 28, 2028. F5 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 28, 2028. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:23 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantCommon Stock | 281,937 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017827 · wk-form4_1773444228.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,937 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F3 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on April 30, 2027. F3 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on April 30, 2027. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:30 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantEmployee Stock Option (Right to Buy) · Derivative | 252,526 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001628280-26-016848 · wk-form4_1773261005.xml · derivative · entry 2 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,526 Underlying: Common Stock · 252,526 shares Expires 2036-03-09 F3 · derivative.exercise_date: The option vests 33% on each of March 9, 2028 and March 9, 2029, and 34% on March 9, 2030. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:30 UTC | MiniMed Group, Inc. MMED · Entity 3758 | GrantPerformance-Based Restricted Stock Units · Derivative | 83,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-016848 · wk-form4_1773261005.xml · derivative · entry 1 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,334 Underlying: Common Stock · 83,334 shares Expires not disclosed F1 · derivative.exercise_price: Each performance-based restricted stock unit represents a contingent right to receive one share of MMED common stock. The performance-based restricted stock units vest on March 9, 2027, subject to MMED common stock achieving a closing price per share of at least $32.05 as of the Divestment Date (as defined in the Separation Agreement, dated March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US Holdco 2, Inc.). F1 · derivative.exercise_date: Each performance-based restricted stock unit represents a contingent right to receive one share of MMED common stock. The performance-based restricted stock units vest on March 9, 2027, subject to MMED common stock achieving a closing price per share of at least $32.05 as of the Divestment Date (as defined in the Separation Agreement, dated March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US Holdco 2, Inc.). F2 · derivative.expiration_date: The later of March 9, 2027 or the Divestment Date. Read SEC document |
| May 06, 2025 Filed May 7, 2025 21:21 UTC | LATTICE SEMICONDUCTOR CORP LSCC · Entity 3335 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 2,671 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015182 · rdgdoc.xml · derivative · entry 3 Dallara Que · CIK 0001756652 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,671 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a right to receive one share of the Issuer's common stock without payment of specific consideration. F4 · derivative.exercise_date: The Restricted Stock Units (RSUs) vest 100% on the first anniversary of the Grant Date. F5 · derivative.expiration_date: Not applicable. Read SEC document |
| May 06, 2025 Filed May 7, 2025 21:21 UTC | LATTICE SEMICONDUCTOR CORP LSCC · Entity 3335 | Exercise / conversionCommon Stock | 2,671 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015182 · rdgdoc.xml · nonDerivative · entry 2 Dallara Que · CIK 0001756652 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted Stock Units (RSUs) - no purchase price for this transaction. Read SEC document |
| May 05, 2025 Filed May 7, 2025 21:21 UTC | LATTICE SEMICONDUCTOR CORP LSCC · Entity 3335 | GrantCommon Stock | 4,193 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-015182 · rdgdoc.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,814 F1 · shares: Represents a grant of Restricted Stock Units (RSUs) which vest 100% on the first anniversary of the date of grant. Read SEC document |
| May 08, 2024 Filed May 9, 2024 22:57 UTC | LATTICE SEMICONDUCTOR CORP LSCC · Entity 3335 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 1,621 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-015773 · rdgdoc.xml · derivative · entry 2 Dallara Que · CIK 0001756652 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,671 Underlying: Common Stock · 1,621 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a right to receive one share of the Issuer's common stock without payment of specific consideration. F3 · derivative.exercise_date: The Restricted Stock Units (RSUs) vest 100% on May 8, 2024. F4 · derivative.expiration_date: Not applicable. Read SEC document |
| May 08, 2024 Filed May 9, 2024 22:57 UTC | LATTICE SEMICONDUCTOR CORP LSCC · Entity 3335 | Exercise / conversionCommon Stock | 1,621 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-015773 · rdgdoc.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units (RSUs) - no purchase price for this transaction. Read SEC document |
| May 06, 2024 Filed May 7, 2024 21:50 UTC | LATTICE SEMICONDUCTOR CORP LSCC · Entity 3335 | GrantRestricted Stock Unit (RSU) · Derivative | 2,671 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-015160 · rdgdoc.xml · derivative · entry 1 Dallara Que · CIK 0001756652 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,292 Underlying: Common Stock · 2,671 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a right to receive one share of the Issuer's common stock without payment of specific consideration. F2 · derivative.exercise_date: The Restricted Stock Units (RSUs) vest 100% on May 6, 2025. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| December 14, 2023 Filed Dec 15, 2023 18:33 UTC | LATTICE SEMICONDUCTOR CORP LSCC · Entity 3335 | GrantRestricted Stock Unit (RSU) · Derivative | 1,621 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-034527 · rdgdoc.xml · derivative · entry 1 Dallara Que · CIK 0001756652 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,621 Underlying: Common Stock · 1,621 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a right to receive one share of the Issuer's common stock without payment of specific consideration. F2 · derivative.exercise_date: The Restricted Stock Units (RSUs) vest 100% on May 8, 2024. F3 · derivative.expiration_date: Not applicable. Read SEC document |
| February 27, 2022 Filed Mar 1, 2022 22:13 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Exercise / conversionRestricted Stock Units · Derivative | 1,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014154 · doc4.xml · derivative · entry 6 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,138 Underlying: Common Stock · 1,186 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Instrument converts to common stock on a one-for-one basis. F3 · shares: Includes the reinvestment of dividend equivalents into 83 additional restricted stock units. F4 · shares: The Restricted Stock Units were adjusted to increase the number of shares in a manner subject to the adjustment provisions of the Garrett Motion Inc. spin-off from Honeywell which occurred on October 1, 2018 and the Resideo Technologies, Inc. spin-off from Honeywell which occurred on October 29, 2018. F5 · derivative.exercise_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates and vest in three equal installments on each of February 27 2020, February 27, 2022 and February 27, 2024. F5 · derivative.expiration_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates and vest in three equal installments on each of February 27 2020, February 27, 2022 and February 27, 2024. F3 · derivative.underlying_shares: Includes the reinvestment of dividend equivalents into 83 additional restricted stock units. F4 · derivative.underlying_shares: The Restricted Stock Units were adjusted to increase the number of shares in a manner subject to the adjustment provisions of the Garrett Motion Inc. spin-off from Honeywell which occurred on October 1, 2018 and the Resideo Technologies, Inc. spin-off from Honeywell which occurred on October 29, 2018. F6 · balance_after: Excludes reinvestment of dividend equivalents during the vesting period. Read SEC document |
| February 27, 2022 Filed Mar 1, 2022 22:13 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Tax withholdingCommon Stock | 536 | $186.90 | $100,178.40 |
DisclosureSEC source: 0001209191-22-014154 · doc4.xml · nonDerivative · entry 4 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,994 Read SEC document |
| February 27, 2022 Filed Mar 1, 2022 22:13 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Exercise / conversionCommon Stock | 1,186 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-014154 · doc4.xml · nonDerivative · entry 3 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Instrument converts to common stock on a one-for-one basis. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 22:13 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Tax withholdingCommon Stock | 1,977 | $186.90 | $369,501.30 |
DisclosureSEC source: 0001209191-22-014154 · doc4.xml · nonDerivative · entry 2 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,344 Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 22:13 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | GrantCommon Stock | 4,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014154 · doc4.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,321 F1 · shares: Shares of common stock acquired pursuant to Performance Stock Units ("PSU") for the performance period 2019-2021, including dividend equivalents. One-half of the PSUs awarded to the reporting person were settled in cash and did not result in the acquisition of beneficial ownership. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 22:51 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Exercise / conversionRestricted Stock Units · Derivative | 994 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-010254 · doc4.xml · derivative · entry 4 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,943 Underlying: Common Stock · 994 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Instrument converts to common stock on a one-for-one basis. F2 · shares: Includes the reinvestment of dividend equivalents into 37 additional restricted stock units. F3 · derivative.exercise_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates with vesting of 33%, 33% and 34% on each of February 14, 2022, February 14, 2024 and February 14, 2026, respectively. F3 · derivative.expiration_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates with vesting of 33%, 33% and 34% on each of February 14, 2022, February 14, 2024 and February 14, 2026, respectively. F2 · derivative.underlying_shares: Includes the reinvestment of dividend equivalents into 37 additional restricted stock units. F4 · balance_after: Excludes reinvestment of dividend equivalents during the vesting period. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 22:51 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Tax withholdingCommon Stock | 449 | $186.48 | $83,729.52 |
DisclosureSEC source: 0001209191-22-010254 · doc4.xml · nonDerivative · entry 2 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,938 Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 22:51 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Exercise / conversionCommon Stock | 994 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-010254 · doc4.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Instrument converts to common stock on a one-for-one basis. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 21:07 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | GrantRestricted Stock Units · Derivative | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009748 · doc4.xml · derivative · entry 2 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed F2 · derivative.exercise_price: Instrument converts to common stock on a one-for-one basis. F3 · derivative.exercise_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates and will vest 33%, 33% and 34% on each of February 11, 2024, February 11, 2026 and February 11, 2028, respectively. F3 · derivative.expiration_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates and will vest 33%, 33% and 34% on each of February 11, 2024, February 11, 2026 and February 11, 2028, respectively. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 21:07 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | GrantEmployee Stock Options · Derivative | 44,200 | $0.00 Strike: $189.72 | $0.00 |
DisclosureSEC source: 0001209191-22-009748 · doc4.xml · derivative · entry 1 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,200 Underlying: Common Stock · 44,200 shares Expires 2032-02-10 F1 · kind: The Employee Stock Options were granted under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates and vest in four equal annual installments, with the first installment vesting on 2/11/2023. F1 · derivative.exercise_date: The Employee Stock Options were granted under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates and vest in four equal annual installments, with the first installment vesting on 2/11/2023. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 21:09 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Exercise / conversionRestricted Stock Units · Derivative | 924 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003320 · doc4.xml · derivative · entry 4 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 924 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Instrument converts to common stock on a one-for-one basis. F2 · shares: All restricted stock units held by the Reporting Person have been adjusted to increase the number of shares in a manner subject to the adjustment provisions of the Garrett Motion Inc. spin-off from Honeywell which occurred on October 1, 2018 and the Resideo Technologies, Inc. spin-off from Honeywell which occurred on October 29, 2018. F3 · shares: Includes the reinvestment of dividend equivalents into 86 additional restricted stock units. F4 · derivative.exercise_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan with vesting on January 13, 2020 and January 13, 2022. F4 · derivative.expiration_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan with vesting on January 13, 2020 and January 13, 2022. F2 · derivative.underlying_shares: All restricted stock units held by the Reporting Person have been adjusted to increase the number of shares in a manner subject to the adjustment provisions of the Garrett Motion Inc. spin-off from Honeywell which occurred on October 1, 2018 and the Resideo Technologies, Inc. spin-off from Honeywell which occurred on October 29, 2018. F3 · derivative.underlying_shares: Includes the reinvestment of dividend equivalents into 86 additional restricted stock units. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 21:09 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Tax withholdingCommon Stock | 444 | $219.98 | $97,671.12 |
DisclosureSEC source: 0001209191-22-003320 · doc4.xml · nonDerivative · entry 2 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,393 Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 21:09 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Exercise / conversionCommon Stock | 924 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-003320 · doc4.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Instrument converts to common stock on a one-for-one basis. Read SEC document |
| December 26, 2021 Filed Dec 28, 2021 22:12 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Exercise / conversionRestricted Stock Units · Derivative | 2,584 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-071397 · doc4.xml · derivative · entry 4 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,488 Underlying: Common Stock · 2,584 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Instrument converts to common stock on a one-for-one basis. F2 · shares: All restricted stock units held by the Reporting Person have been adjusted to increase the number of shares in a manner subject to the adjustment provisions of the Garrett Motion Inc. spin-off from Honeywell which occurred on October 1, 2018 and the Resideo Technologies, Inc. spin-off from Honeywell which occurred on October 29, 2018. F3 · shares: Includes the reinvestment of dividend equivalents into 171 additional restricted stock units. F4 · derivative.exercise_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan with vesting on December 26, 2019, December 26, 2021 and December 26, 2023. F4 · derivative.expiration_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan with vesting on December 26, 2019, December 26, 2021 and December 26, 2023. F2 · derivative.underlying_shares: All restricted stock units held by the Reporting Person have been adjusted to increase the number of shares in a manner subject to the adjustment provisions of the Garrett Motion Inc. spin-off from Honeywell which occurred on October 1, 2018 and the Resideo Technologies, Inc. spin-off from Honeywell which occurred on October 29, 2018. F3 · derivative.underlying_shares: Includes the reinvestment of dividend equivalents into 171 additional restricted stock units. F2 · balance_after: All restricted stock units held by the Reporting Person have been adjusted to increase the number of shares in a manner subject to the adjustment provisions of the Garrett Motion Inc. spin-off from Honeywell which occurred on October 1, 2018 and the Resideo Technologies, Inc. spin-off from Honeywell which occurred on October 29, 2018. F5 · balance_after: Excludes reinvestment of dividend equivalents during the vesting period. Read SEC document |
| December 26, 2021 Filed Dec 28, 2021 22:12 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Tax withholdingCommon Stock | 1,166 | $205.22 | $239,286.52 |
DisclosureSEC source: 0001209191-21-071397 · doc4.xml · nonDerivative · entry 2 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,913 Read SEC document |
| December 26, 2021 Filed Dec 28, 2021 22:12 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Exercise / conversionCommon Stock | 2,584 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-071397 · doc4.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Instrument converts to common stock on a one-for-one basis. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 01:47 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | SaleCommon Stock | 10,759 | $231.28 | $2,488,341.52 |
DisclosureSEC source: 0001209191-21-051012 · doc4.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,495 F1 · price: The price reported in this column is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.23 to $231.31, inclusive. The Reporting Person undertakes to provide to Honeywell International Inc., any security holder of Honeywell International Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 27, 2021 Filed Mar 3, 2021 01:28 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Tax withholdingCommon Stock | 2,472 | $204.93 | $506,586.96 |
DisclosureSEC source: 0001209191-21-016540 · doc4.xml · nonDerivative · entry 4 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,150 Read SEC document |
| February 27, 2021 Filed Mar 3, 2021 01:28 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | GrantCommon Stock | 5,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016540 · doc4.xml · nonDerivative · entry 3 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,642 Read SEC document |
| February 26, 2021 Filed Mar 3, 2021 01:28 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Exercise / conversionRestricted Stock Units · Derivative | 888 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016540 · doc4.xml · derivative · entry 6 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,742 Underlying: Common Stock · 888 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Instrument converts to common stock on a one-for-one basis. F2 · shares: Includes the reinvestment of dividend equivalents into 30 additional restricted stock units. F3 · derivative.exercise_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates and vested in three equal installments on each of February 26, 2021, February 26, 2023 and February 26, 2025. F3 · derivative.expiration_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates and vested in three equal installments on each of February 26, 2021, February 26, 2023 and February 26, 2025. F2 · derivative.underlying_shares: Includes the reinvestment of dividend equivalents into 30 additional restricted stock units. F4 · balance_after: Excludes reinvestment of dividend equivalents during the vesting period. Read SEC document |
| February 26, 2021 Filed Mar 3, 2021 01:28 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Tax withholdingCommon Stock | 401 | $203.94 | $81,779.94 |
DisclosureSEC source: 0001209191-21-016540 · doc4.xml · nonDerivative · entry 2 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,142 Read SEC document |
| February 26, 2021 Filed Mar 3, 2021 01:28 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Exercise / conversionCommon Stock | 888 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-016540 · doc4.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Instrument converts to common stock on a one-for-one basis. Read SEC document |
| February 12, 2021 Filed Feb 16, 2021 21:47 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | GrantRestricted Stock Units · Derivative | 2,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-010787 · doc4.xml · derivative · entry 2 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,800 Underlying: Common Stock · 2,800 shares Expires not disclosed F2 · derivative.exercise_price: Instrument converts to common stock on a one-for-one basis. F3 · derivative.exercise_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates and will vest 33%, 33% and 34% on each of February 12, 2023, February 12, 2025 and February 12, 2027, respectively. F3 · derivative.expiration_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates and will vest 33%, 33% and 34% on each of February 12, 2023, February 12, 2025 and February 12, 2027, respectively. Read SEC document |
| February 12, 2021 Filed Feb 16, 2021 21:47 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | GrantEmployee Stock Options · Derivative | 42,500 | $0.00 Strike: $202.72 | $0.00 |
DisclosureSEC source: 0001209191-21-010787 · doc4.xml · derivative · entry 1 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 42,500 shares Expires 2031-02-11 F1 · kind: The Employee Stock Options were granted under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates and vest in four equal annual installments, with the first installment vesting on 2/12/2022. F1 · derivative.exercise_date: The Employee Stock Options were granted under the 2016 Stock Incentive Plan of Honeywell International Inc. and its Affiliates and vest in four equal annual installments, with the first installment vesting on 2/12/2022. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 23:27 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Exercise / conversionRestricted Units · Derivative | 1,986 | $0.00 | $0.00 |
DisclosureSEC source: 0000950117-20-000132 · cfp_24625.xml · derivative · entry 5 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,986 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Instrument converts to common stock on a one-for-one basis. F2 · shares: Includes the reinvestment of dividend equivalents into 105 additional restricted stock units. F3 · shares: All options and restricted stock units held by the Reporting Person have been adjusted to increase the number of shares and, in the case of the options, reduce the exercise price, in a manner subject to the adjustment provisions of the Garrett Motion Inc. spin-off from Honeywell which occurred on October 1, 2018 and the Resideo Technologies, Inc. spin-off from Honeywell which occurred on October 29, 2018. F4 · derivative.exercise_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan with all units vesting on February 28, 2020. F4 · derivative.expiration_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan with all units vesting on February 28, 2020. F2 · derivative.underlying_shares: Includes the reinvestment of dividend equivalents into 105 additional restricted stock units. F3 · derivative.underlying_shares: All options and restricted stock units held by the Reporting Person have been adjusted to increase the number of shares and, in the case of the options, reduce the exercise price, in a manner subject to the adjustment provisions of the Garrett Motion Inc. spin-off from Honeywell which occurred on October 1, 2018 and the Resideo Technologies, Inc. spin-off from Honeywell which occurred on October 29, 2018. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 23:27 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Tax withholdingCommon Stock | 1,699 | $156.40 | $265,723.60 |
DisclosureSEC source: 0000950117-20-000132 · cfp_24625.xml · nonDerivative · entry 3 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,454 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 23:27 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Tax withholdingCommon Stock | 897 | $156.40 | $140,290.80 |
DisclosureSEC source: 0000950117-20-000132 · cfp_24625.xml · nonDerivative · entry 2 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,153 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 23:27 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Exercise / conversionCommon Stock | 1,986 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950117-20-000132 · cfp_24625.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · President & CEO, HCE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Instrument converts to common stock on a one-for-one basis. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:15 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Exercise / conversionRestricted Units · Derivative | 1,141 | $0.00 | $0.00 |
DisclosureSEC source: 0000950117-20-000118 · cfp_24608.xml · derivative · entry 4 Dallara Que · CIK 0001756652 · Pres/CEO-Connected Enterprise 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,241 Underlying: Common Stock · 1,141 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Instrument converts to common stock on a one-for-one basis. F2 · shares: Includes the reinvestment of dividend equivalents into 39 additional restricted stock units. F3 · shares: All options and restricted stock units held by the Reporting Person have been adjusted to increase the number of shares and, in the case of the options, reduce the exercise price, in a manner subject to the adjustment provisions of the Garrett Motion Inc. spin-off from Honeywell which occurred on October 1, 2018 and the Resideo Technologies, Inc. spin-off from Honeywell which occurred on October 29, 2018. F4 · derivative.exercise_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan with vesting on February 27, 2020, February 27, 2022 and February 27, 2024. F4 · derivative.expiration_date: The Restricted Stock Units were granted under the 2016 Stock Incentive Plan with vesting on February 27, 2020, February 27, 2022 and February 27, 2024. F2 · derivative.underlying_shares: Includes the reinvestment of dividend equivalents into 39 additional restricted stock units. F3 · derivative.underlying_shares: All options and restricted stock units held by the Reporting Person have been adjusted to increase the number of shares and, in the case of the options, reduce the exercise price, in a manner subject to the adjustment provisions of the Garrett Motion Inc. spin-off from Honeywell which occurred on October 1, 2018 and the Resideo Technologies, Inc. spin-off from Honeywell which occurred on October 29, 2018. F3 · balance_after: All options and restricted stock units held by the Reporting Person have been adjusted to increase the number of shares and, in the case of the options, reduce the exercise price, in a manner subject to the adjustment provisions of the Garrett Motion Inc. spin-off from Honeywell which occurred on October 1, 2018 and the Resideo Technologies, Inc. spin-off from Honeywell which occurred on October 29, 2018. F5 · balance_after: Excludes reinvestment of dividend equivalents during the vesting period. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:15 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Tax withholdingCommon Stock | 515 | $163.18 | $84,037.70 |
DisclosureSEC source: 0000950117-20-000118 · cfp_24608.xml · nonDerivative · entry 2 Dallara Que · CIK 0001756652 · Pres/CEO-Connected Enterprise 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,064 Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 22:15 UTC | HONEYWELL INTERNATIONAL INC HON · Entity 2988 | Exercise / conversionCommon Stock | 1,141 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950117-20-000118 · cfp_24608.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · Pres/CEO-Connected Enterprise 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Instrument converts to common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.